In a @-week multicentre randomised placebo-controlled superiority trial , @ DMARD-nave patients with early clinical synovitis ( @ tender and swollen joint , and within @ months of diagnosis ) and either rheumatoid factor , anticitrullinated protein antibodies or shared epitope positive were randomised @:@ to receive MTX+ETN or MTX + placebo ( PBO ) for @ weeks .